Blakemore, Marsden, and Vater
THF, 0.29 mmol) and the entire apparatus was cooled by submergence in a –78 °C cold bath. After allowing a
suitable time period for the attainment of thermal equilibrium (ca. 20 min, with stirring), the apparatus was
gently tilted to effect the portionwise addition (six portions) of the solution of sulfoxide 8 to the Grignard
reagent during 17 min. The connecting tube remained submerged in the cooling bath throughout this operation.
The reaction mixture was afforded 30 min to stir at –78 °C during which time the compartment previously
occupied by the sulfoxide was charged with a mixture of benzaldehyde (36 µL, d = 1.04, 37 mg, 0.35 mmol) and
Me2AlCl (0.35 mL, 1.0 M in hexanes, 0.35 mmol) in THF (2.5 mL). The apparatus was tilted as before to add
the now chilled mixture of benzaldehyde/Me2AlCl to the carbenoid solution in four portions during 15 min. The
reaction mixture was then allowed to warm steadily to –30 oC over the following 13.5 h before being quenched
by the addition of sat. aq. NH4Cl (1 mL). The layers of the resulting biphasic mixture were separated and the
aqueous phase was extracted with t-BuOMe (3x10 mL). The combined organic phases were then washed
successively with H2O (5 mL) and brine (5 mL), dried (Na2SO4) and concentrated in vacuo. The residue was
purified by column chromatography (eluting with 10% EtOAc in hexanes) to afford the title compound (S3, 33
mg, 0.134 mmol, 63%, dr(∗) = 93:7 as adjudged by 1H NMR spectral analysis) as a colorless oil: IR (neat) 3423,
1
3027, 1602, 1495, 1454, 1064, 1028, 746, 696 cm–1; H NMR (300 MHz, CDCl3, signals attributable to major
isomer only) δ 7.47-7.12 (10 H, m), 4.77 (1H, t, J = 5.4 Hz), 4.34 (1H, dt, J = 9.2, 5.4 Hz), 3.11 (1H, dd, J =
13
14.2, 5.4 Hz), 2.94 (1H, dd, J = 14.2, 9.2 Hz), 2.72 (1H, d, J = 5.4 Hz, OH) ppm; C NMR (75 MHz, CDCl3,
signals attributable to major isomer only) δ 140.3 (0), 137.6 (0), 129.4 (2C, 1), 128.8 (2C, 1), 128.7 (2C, 1),
1
128.5 (1), 127.1 (1), 126.7 (2C, 1), 76.0 (1), 70.1 (1), 41.1 (2) ppm. H and 13C NMR data were in agreement
with those previously reported by Hoffmann et al.1
(2S,3R)-cis-2-Benzyl-3-phenyloxirane (cis-12) and (2S,3S)-trans-2-benzyl-3-phenyloxirane (trans-12):
Following the method of Hoffmann and co-workers,1 a solution of chlorohydrin S3 (16 mg, 0.065 mmol, dr(∗) =
93:7) in EtOH (1.5 mL) at 0 °C was treated with an ethanolic solution of KOH (0.32 mL, 0.40 M in EtOH, 0.13
mmol) during 30 s. The resulting mixture was stirred at rt for 19 h and was then treated with NH4Cl (115 mg,
2.15 mmol) and concentrated in vacuo. The residue was partitioned between t-BuOMe (10 mL) and sat. aq.
NH4Cl (5 mL) and the layers well shaken and separated. The aqueous phase was extracted with t-BuOMe (3x10
mL) and the combined organic phases were washed with brine (2x5 mL), dried (Na2SO4) and concentrated in
vacuo. The residue was purified by column chromatography (eluting with 10% EtOAc in hexanes) to afford the
title compounds (cis-12 and trans-12, 11 mg, 0.052 mmol, 80%) as an inseparable mixture of colorless oils (cis:
1
1
trans = 94:6 as adjudged by H NMR spectral analysis): IR (neat) 3027, 1602, 1495, 1454, 743, 696 cm–1; H
NMR (300 MHz, CDCl3, signals attributable to cis-12 only) δ 7.43-7.16 (8H, m), 7.04 (2H, d, J = 6.4 Hz), 4.17
(1H, d, J = 4.1 Hz), 3.44 (1H, td, J = 6.4, 4.1 Hz), 2.77 (1H, dd, J = 14.6, 6.4 Hz), 2.56 (1H, dd, J = 14.6, 6.4
Hz) ppm; 13C NMR (75 MHz, CDCl3, signals attributable to cis-12 only) δ 137.6 (0), 135.5 (0), 129.0 (2C, 1),
128.7 (2C, 1), 128.3 (2C, 1), 127.9 (1), 126.8 (2C, 1), 126.7 (1), 59.9 (1), 57.8 (1), 33.4 (2) ppm; MS (ES+) m/z
211 [42, (M+H)+], 115 (100). H and 13C NMR data were in agreement with those previously reported by
1
Hoffmann and Schulze.11
HPLC analysis of the mixture of cis-12 and trans-12 obtained in the above experiment using two different chiral
stationary phases permitted determination of %ee for both diastereoisomers. Thus, analysis of a racemic sample
of 12 exhibiting cis:trans ~ 3:1 with a Daicel Chiralcel® AS-RH column, eluting with 40-55% MeCN in H2O
(over 30 min) at 1.0 mL min–1 and monitored by UV at 210 nm, gave resolved peaks tret. (cis-12 + ent-cis-12) =
19.0 min, tret. (trans-12) = 20.4 min, and tret. (ent-trans-12) = 26.0 min (Figure S1). Analysis of the same sample
with a Daicel Chiralcel® OD-RH column, eluting with 40-55% MeCN in H2O (over 30 min) at 1.0 mL min–1
11. Schulze, V.; Hoffmann, R. W. Chem. Eur. J. 1999, 5, 337.